Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rani Therapeutics Holdings (RANI)
NASDAQ:RANI
RESEARCH TOOLSreports
Holding RANI?
Track your performance easily
Rani Therapeutics Holdings (RANI) Ownership Overview
30.62% Insiders
2.83% Mutual Funds
1.92% Other Institutional Investors
2.47% ETFs
62.16% Public Companies and Individual Investors
The ownership structure of Rani Therapeutics Holdings (RANI) stock is a mix of institutional, retail, and individual investors. Approximately 7.22% of the company’s stock is owned by Institutional Investors, 30.62% is owned by Insiders, and 62.16% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 17, 2024 | South Cone Investments Limited Partnership >10% Owner | xxxxxxxxxxxxx | $10131485 |
| Dec 08, 2023 | South Cone Investments Limited Partnership >10% Owner | xxxxxxxxxxxxx | $10582982 |
| Dec 08, 2023 | Isidoro Alfonso Quiroga Cortes >10% Owner | xxxxxxxxxxxxx | $10582982 |
| Dec 07, 2023 | Imran Talat Ceo,director | xxxxxxxxxxxxx | $22700 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,302,194 | Insider | 25.71% | 21,751,748 | |
| 691,678 | Institution | 2.14% | 1,812,196 | |
| 691,678 | Institution | 2.14% | 1,812,196 | |
| 484,455 | Insider | 1.50% | 1,269,272 | |
| 273,265 | Insider | 0.85% | 715,954 | |
| 260,389 | Insider | 0.81% | 682,219 | |
| 258,597 | Insider | 0.80% | 677,524 | |
| 163,216 | Insider | 0.51% | 427,626 | |
| 133,744 | Institution | 0.41% | 350,409 | |
| 105,604 | Institution | 0.33% | 276,682 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 691,678 | Institution | 2.14% | 1,812,196 | |
| 133,744 | Institution | 0.41% | 350,409 | |
| 71,500 | Institution | 0.22% | 187,330 | |
| 14,248 | Institution | 0.04% | 37,330 | |
| 3,316 | Institution | 0.01% | 8,688 | |
| 594 | Institution | <0.01% | 1,556 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 518,702 | Institution | 1.61% | 1,120,396 | |
| 172,976 | Institution | 0.54% | 373,628 | |
| 105,604 | Institution | 0.33% | 254,506 |
FAQ
Who Owns Rani Therapeutics Holdings (RANI)?
According to the latest TipRanks data, approximately 1.92% of the company's stock is held by institutional investors, 30.62% is held by insiders, and 62.16% is held by retail investors.
What percentage of Rani Therapeutics Holdings (RANI) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.92% of Rani Therapeutics Holdings (RANI) stock is held by institutional investors.
What percentage of Rani Therapeutics Holdings (RANI) stock is held by retail investors?
According to the latest TipRanks data, approximately 62.16% of Rani Therapeutics Holdings (RANI) stock is held by retail investors.
Who owns the most shares of Rani Therapeutics Holdings (RANI)?
South Cone Investments Limited Partnership owns the most shares of Rani Therapeutics Holdings (RANI).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.